LEE, SOO YOUNG,이수영,YI, KYE SOOK,이계숙,KIM, CHEOL MIN,김철민,YOON, JOON SUN,윤준선,RYU, SOO HEE,류수희,LEE, HWA JIN,이화진,SONG, HANNA,송경민,BAE, YEON JIN,배연진,LEE, HYUN JOO,이현주,SHIM, EUN YEONG,심은영,LEE, SOO YOUNGKR,YI, KYE SOOKKR,KIM, CHEOL MINKR,YOON, JOON SUNKR,RYU, SOO HEEKR,LEE, HWA JINKR,SONG, HANNAKR,BAE, YEON JINKR,LEE, HYUN JOOKR,SHIM, EUN YEONGKR
申请号：
KR1020160150961
公开号：
KR1018287940000B1
申请日:
2016.11.14
申请国别(地区):
KR
年份:
2018
代理人:
摘要：
The present invention relates to an antibody with neutralizing activity against middle east respiratory syndrome-coronavirus (MERS-CoV). More specifically, the present invention relates to a human monoclonal antibody having an excellent binding ability to S protein of MERS-CoV and having a neutralization effect on MERS-CoV. The human monoclonal antibody is very useful for the prevention, treatment or diagnosis of MERS-CoV infection.본 발명은 중동호흡기증후군 코로나바이러스(Middle East Respiratory Syndrome-Coronavirus, MERS-CoV)에 중화 활성을 갖는 항체에 관한 것이다. 보다 구체적으로는, MERS-CoV의 S 단백질에 대한 우수한 결합 능력을 가지며 MERS-CoV에 중화 효과를 갖는 인간 단일클론 항체에 관한 것으로, MERS-CoV 감염에 대한 예방, 치료 또는 진단에 매우 유용하다.
